Fortis Malar Hospitals Ltd
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of providing health care & medical services[1]
- Market Cap ₹ 99.2 Cr.
- Current Price ₹ 53.0
- High / Low ₹ 108 / 44.0
- Stock P/E
- Book Value ₹ 15.9
- Dividend Yield 80.3 %
- ROCE -3.29 %
- ROE -9.12 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is providing a good dividend yield of 80.3%.
Cons
- Stock is trading at 3.33 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -16.4% over past five years.
- Company has a low return on equity of -13.0% over last 3 years.
- Earnings include an other income of Rs.62.3 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98 | 108 | 118 | 130 | 141 | 149 | 145 | 112 | 69 | 86 | 86 | 59 | 23 | |
86 | 99 | 110 | 123 | 140 | 147 | 147 | 115 | 76 | 83 | 81 | 60 | 25 | |
Operating Profit | 11 | 9 | 8 | 6 | 1 | 2 | -2 | -3 | -6 | 3 | 5 | -1 | -2 |
OPM % | 12% | 8% | 6% | 5% | 1% | 1% | -2% | -2% | -9% | 4% | 5% | -2% | -8% |
49 | 7 | 8 | 7 | 8 | 8 | 10 | 11 | 15 | 7 | 7 | 65 | 62 | |
Interest | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 8 | 7 | 7 | 6 | 4 | 2 |
Depreciation | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 13 | 13 | 13 | 12 | 9 | 4 |
Profit before tax | 57 | 13 | 12 | 10 | 4 | 6 | 3 | -12 | -11 | -8 | -7 | 50 | 55 |
Tax % | 24% | 34% | 34% | 36% | 30% | 41% | 26% | -25% | -30% | 0% | 121% | 9% | |
43 | 9 | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -15 | 45 | 50 | |
EPS in Rs | 23.38 | 4.72 | 4.23 | 3.45 | 1.67 | 1.78 | 1.10 | -4.74 | -4.20 | -4.41 | -8.26 | 24.18 | 26.73 |
Dividend Payout % | -0% | 11% | 12% | 14% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 176% |
Compounded Sales Growth | |
---|---|
10 Years: | -6% |
5 Years: | -16% |
3 Years: | -5% |
TTM: | -71% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 14% |
TTM: | 75% |
Stock Price CAGR | |
---|---|
10 Years: | 4% |
5 Years: | 1% |
3 Years: | -6% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | -3% |
5 Years: | -13% |
3 Years: | -13% |
Last Year: | -9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
Reserves | 59 | 66 | 73 | 79 | 81 | 84 | 87 | 78 | 70 | 61 | 45 | 91 | 11 |
-0 | -0 | -0 | -0 | -0 | -0 | -0 | 64 | 57 | 53 | 46 | -0 | -0 | |
14 | 17 | 20 | 33 | 31 | 46 | 45 | 33 | 23 | 27 | 27 | 6 | 7 | |
Total Liabilities | 91 | 101 | 111 | 130 | 131 | 149 | 151 | 194 | 169 | 161 | 138 | 116 | 37 |
17 | 18 | 18 | 24 | 25 | 24 | 22 | 81 | 69 | 58 | 47 | -0 | -0 | |
CWIP | -0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | -0 | -0 | -0 |
Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
73 | 83 | 93 | 105 | 105 | 125 | 128 | 112 | 100 | 103 | 91 | 116 | 37 | |
Total Assets | 91 | 101 | 111 | 130 | 131 | 149 | 151 | 194 | 169 | 161 | 138 | 116 | 37 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-64 | 5 | 4 | 10 | -9 | 9 | -16 | -0 | -1 | 7 | 6 | -7 | |
73 | -1 | 5 | -22 | 13 | -2 | 6 | 50 | -28 | 8 | 0 | 120 | |
-7 | -1 | -0 | -1 | -1 | 0 | 0 | -12 | -7 | -10 | -13 | -11 | |
Net Cash Flow | 2 | 3 | 10 | -13 | 4 | 7 | -9 | 38 | -36 | 5 | -7 | 102 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12 | 13 | 13 | 17 | 14 | 15 | 24 | 12 | 11 | 9 | 14 | -0 |
Inventory Days | 7 | 4 | 13 | 35 | 28 | 22 | 18 | 22 | 42 | 40 | 32 | -0 |
Days Payable | 160 | 153 | 169 | 286 | 174 | 277 | 257 | 324 | 373 | 429 | 585 | |
Cash Conversion Cycle | -141 | -136 | -143 | -234 | -131 | -240 | -215 | -289 | -320 | -380 | -539 | -0 |
Working Capital Days | 212 | 187 | 164 | 126 | 153 | 132 | 156 | -55 | 134 | 51 | 219 | -8 |
ROCE % | 23% | 17% | 14% | 12% | 5% | 6% | 3% | -3% | -7% | -1% | -1% | -3% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Nov
-
Outcome Of Board Meeting In Accordance With The SEBI (LODR) Regulations, 2015.
5 Nov - Approval of financial results and key appointments.
-
Appointment of Company Secretary and Compliance Officer
5 Nov - Approval of financial results and key management appointments.
-
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With The SEBI (LODR) Regulations, 2015.
5 Nov - Approval of financial results and key appointments.
-
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (LODR) Regulations, 2015.
28 Oct - Notice of Board Meeting to approve financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is a part of Fortis Group, being subsidiary of Fortis Hospitals Limited and Intermediate Holding Company of Fortis Healthcare Ltd. The Hospital building is owned by a fellow subsidiary, Fortis Health Management Limited. Company has entered into Hospital and Medical Services Agreement
with FHML for rendering of medical and healthcare services at the hospital building